OMNIPOD INSULIN MANAGEMENT SYSTEM— 510(k) K140439

Name: FDA 510(k) clearance K140439
Creator: U.S. Food and Drug Administration
Published: 2014-11-13

Substantially Equivalent

Insulet Corporation

FDA 510(k) clearance K140439 for OMNIPOD INSULIN MANAGEMENT SYSTEM, Substantially Equivalent on 2014-11-13. Applicant: Insulet Corporation. Device class: 2.

Clearance details

Applicant: Insulet Corporation
Product code: Code LZG
Device class: Class 2
Regulation: 21 CFR 880.5725
Advisory panel: General Hospital
Date received: 2014-02-21
Decision date: 2014-11-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LZG

view all

K262153 — Pivot Insulin Delivery System2026-09-02
K253534 — Pivot Insulin Delivery System2026-04-08
K240158 — Modular Medical MODD1 Insulin Delivery System2024-09-04
K241622 — Extended Reservoir; MiniMed Reservoir2024-07-02
K223372 — Omnipod GO Insulin Delivery Device2023-04-24

More clearances from Insulet Corporation

view all

K261461 — Omnipod 6 algorithm2026-06-29
K251779 — Omnipod 5 algorithm2025-12-03
K241777 — SmartAdjust Technology2024-08-26
K232741 — SmartAdjust(TM) technology2024-05-29
K231824 — SmartBolus Calculator2023-10-18

Adverse events under product code LZG

product code LZG

Death: 104
Injury: 12,022
Malfunction: 135,004
Other: 1
Total: 147,131

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.